Novartis IndiaBOM:500672 +0.17%59 Dividend Yield % is 1.74% as of Jun. 30, 2026, which is 14% above its 10-year median of 1.52. GuruFocus rates BOM:500672 with a GF Score™ of 59/100 and a GF Value™ of ₹928.24 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 517 Drug Manufacturers companies, Novartis India ranks worse than 55.13% on this metric.
As of today (2026-06-30), the Trailing Annual Dividend Yield of Novartis India is 1.74%.
Warning Sign:
Novartis India Ltd stock Dividend Yield % is close to 1-year low.
The historical rank and industry rank for Novartis India's Dividend Yield % or its related term are showing as below:
BOM:500672'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.85 Med: 1.52 Max: 3.29
Current: 1.74
During the past 13 years, the highest Dividend Yield of Novartis India was 3.29%. The lowest was 0.85%. And the median was 1.52%.
BOM:500672's Dividend Yield % is ranked worse than 55.13% of 517
companies
in the Drug Manufacturers industry
Industry Median: 2.04
vs BOM:500672: 1.74
During the past 3 years, the average Dividends Per Share Growth Rate was 35.70% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 23.30% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 7.80% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Novartis India was 35.70% per year. The lowest was -20.60% per year. And the median was 0.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Novartis India (BOM:500672) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Novartis India's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:500672 vs ZTS, UTHR: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Novartis India's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novartis India Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Novartis India's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Novartis India's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Novartis India Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 25.000000
2025-07-23
2025-07-24
2025-08-04
Cash Dividend
annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Novartis India's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novartis India (BOM:500672) has a Dividend Yield % of 1.74% as of Jun. 30, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Novartis India and its competitors. This is 14% above median its historical median of 1.52. Over the past decade, Novartis India's Dividend Yield % has ranged from 0.85 to 3.29. According to the industry distribution chart, Novartis India ranks #285 out of 517 companies in the Drug Manufacturers industry, placing it in the top 55.1%.
Is Novartis India's Dividend Yield % too high?
Novartis India's current Dividend Yield % of 1.74% is 14% above median its 10-year median of 1.52. Over the past 10 years, this metric has ranged from a low of 0.85 to a high of 3.29. The Drug Manufacturers industry median Dividend Yield % is 2.04. Novartis India's value of 1.74% is 14.7% below this industry median. Based on the distribution chart, Novartis India ranks #285 out of 517 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Novartis India has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Novartis India's Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Novartis India ranks #285 out of 517 companies for Dividend Yield %. This places Novartis India in the lower half of its industry. The industry median Dividend Yield % is 2.04. Novartis India's value of 1.74% is 14.7% below this benchmark. Historically, Novartis India's own Dividend Yield % has ranged from 0.85 to 3.29 over the past decade. While the company's 10-year median is 1.52 vs. the industry median of 2.04, Novartis India has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.04, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novartis India's current Dividend Yield % of 1.74% is 14.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Novartis India and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novartis India's current Dividend Yield % is 1.74%, which is 14% above median its own 10-year median of 1.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novartis India stock overvalued right now?
Based on GuruFocus' analysis, Novartis India (BOM:500672) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹928.24, compared to a current price of ₹1,440.95 — trading 55.2% above its estimated fair value. The current Dividend Yield % is 1.74%, which is 14% above median its 10-year median of 1.52 and 14.7% below the Drug Manufacturers industry median of 2.04. Novartis India's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Novartis India (BOM:500672), the current Dividend Yield % is 1.74% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novartis India (BOM:500672) Overvalued in 2026?
Based on GuruFocus' analysis, Novartis India stock appears to be overvalued.
The current stock price of ₹1,440.95 is trading 55.2% above its estimated GF Value™ of ₹928.24.
GuruFocus considers Novartis India to be Significantly Overvalued.
Key valuation signals for BOM:500672:
Dividend Yield %: 1.74% (14% above median its 10-year median of 1.52)
GF Value™: ₹928.24 vs. price of ₹1,440.95 (55.2% above fair value)
Industry Position: 14.7% below the Drug Manufacturers median (#285 of 517)
No single metric tells the full story. See the BOM:500672 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company operates in a single business segment, namely Pharmaceutical Business. Its Pharmaceutical business focuses on Bone and Pain, Transplantation Immunology, and Neurosciences.
59GF Score
Get the complete analysis for BOM:500672
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500672 has been successfully added to your 
